Blood thinner breakthrough could stop clots in rare anemia

This study tests whether taking blood thinners for 12 weeks can prevent dangerous blood clots in people with autoimmune hemolytic anemia (AIHA), a rare disease where the immune system destroys red blood cells. About 72 adults with newly diagnosed or relapsed AIHA will receive either standard care or extended blood-thinner treatment. The goal is to see if longer prevention reduces the high risk of clots during the first three months after diagnosis or relapse.